Page 422 - Health News

Delhi records 496 new Covid cases in a day, highest since June 4

The positivity rate went up to 0.89%

Covid-19 pandemic: Nashik sees 47 cases, 2 deaths, 51 recoveries

3,224 samples were examined for Covid-19 on Tuesday

Delhi Metro trains to run at 50% seating capacity; no standing commuters

DTC and other city buses shall also ply with only 50 per cent of the total seating capacity in view of the new norms

Fresh Covid curbs in Delhi a 'death warrant' for fitness industry: Traders

The Delhi Disaster Management Authority (DDMA) on Tuesday ordered the closure of schools, colleges, cinemas and gyms with immediate effect

Baijal to chair DDMA meet on Wednesday to review Covid situation

The agenda of the meeting is to review the Covid-19 situation in Delhi and discuss preparations in the wake of rising Omicron cases

Covid: 7 more Omicron infections in Kerala takes tally to 64

Of the seven cases, four were detected in Pathanamthitta, two in Alappuzha and one in Thiruvananthapuram

Kerala logs 2,474 fresh Covid-19 cases, 244 deaths

As many as 60,597 samples were tested in the last 24 hours

Fresh Covid curbs will hurt shopkeepers, say Delhi traders

With the authorities imposing fresh Covid restrictions in Delhi on Tuesday, traders said it will be a "death warrant" for the fitness industry and make a "big dent" in their businesses.

Amid Omicron threat, India's Covid arsenal has 8 vaccines, 4 treatments

The CDSCO has granted restricted emergency use authorisation to two new vaccines and a drug for Covid-19, taking to 12 the number of preventives and treatments available in India

China's Xi'an logs 811 Covid cases amid surge in coronavirus infections

Xi'an, capital of China's Shaanxi Province reported 175 confirmed locally transmitted Covid cases on Monday, taking the total tally to 811 amid the surge in coronavirus cases, local media reported.

Study shows coronavirus can infect kidneys and lead to scarring

A team of international researchers have shown that SARS-CoV-2, virus causing Covid-19, infects the kidneys and contributes to tissue scarring, possibly impacting kidney outcomes in the long term.

Dr Reddy's Laboratories to introduce Molnupiravir to treat Covid-19 shortly

The Hyderabad-based firm said it will introduce the drug under the brand name Molflu in India

Pharma players to launch anti-Covid pill shortly after DCGI approval

Homegrown pharma majors Sun Pharma, Cipla, Hetero, Torrent announced plans to market their versions of antiviral drug Molnupiravir to treat high-risk adult patients with Covid across India shortly.

Hetero gets DCGI nod to manufacture, market Molnupiravir capsules

Hetero said it has received permission from DCGI for manufacturing and marketing Molnupiravir capsules of 200 mg strength that is used to treat high-risk Covid adult patients.

Omicron effect: Delhi imposes more curbs on social activities, transport

Spas, gyms, yoga institutes and entertainment parks will remain closed, but outdoor yoga will be allowed

Delhi Covid curbs: Cinemas, gyms shut; malls to stay open on odd-even basis

Night curfew will be imposed from 10 pm to 5 am; Delhi Metro, restaurants, bars to operate at 50% capacity

Torrent Pharma to launch Molnupiravir under brand name Molnutor in India

The Drugs Controller General of India (DCGI), based on the review of clinical data of Molnupiravir has approved the drug for the treatment of Covid-19 in adults for restricted emergency use in India

No need for doctor certificate on co-morbidities for precaution dose: Govt

People aged 60 years and above with co-morbidities, who have received two doses of Covid vaccine, will on doctor's advice be provided with the precaution dose from Jan 10

Covid: Full list of restrictions as yellow alert sounded in Delhi

Delhi Chief Minister Arvind Kejriwal declared a yellow alert in the wake of a spike, restrictions will be imposed in the national capital under Level 1 of the Graded Action Response Plan

Bharat Biotech targets one billion doses of intranasal vaccine annually

The Hyderabad-based vaccine maker has already approached the Drug Controller General of India (DCGI) for approval to conduct phase-III trials of its intranasal vaccine